KREBSBIO2023-04-012023-06-30 KREBSBIO2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member KREBSBIO2023-06-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524518 KREBSBIO NA Krebs Biochemicals and Industries Limited Equity 2023-04-01 2024-03-31 2023-08-09 2023-07-21 INR Lakhs First quarter 13:00:00 16:00:00 2023-08-09 2023-08-09 Not applicable Single segment Manufacturing of Drugs 2023-04-01 2023-06-30 Unaudited Standalone 105813000.00 375000.00 106188000.00 19663000.00 0.00 -16010000.00 40638000.00 10973000.00 16532000.00 87721000.00 159517000.00 -53329000.00 0.00 -53329000.00 0.00 0.00 0.00 0.00 -53329000.00 0.00 0.00 0.00 0.00 -53329000.00 0.00 -53329000.00 0.00 0.00 215606000.00 10 -2.47 -2.47 0.00 0.00 -2.47 -2.47 0.00 0.00 0.00 1. The above results have been reviewed by the Audit Committee at its meeting held on 09th August, 2023 and approved by the Board of Directors of the Company at its meeting held on 09th August, 2023. 2. The Company is operating in one segment only hence no segment results have been disclosed. 3. The figures for the preceding quarter ended 31.03.2023 are the balancing figures between the audited figures in respect of the full financial year and published year to date figures up to third quarter of the relevant financial year. 4. The above financial results are prepared in accordance with IND AS notified under the Company (Indian Accounting Standards) Rules, 2015. Other Expenses 87721000.00 0.00 0.00